Amicus Therapeutics (GB:0HF9)
LSE:0HF9
Holding GB:0HF9?
Track your performance easily

Amicus (0HF9) Financial Statements

0 Followers

Amicus Financial Overview

Amicus's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Amicus is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 126.67M$ 110.40M$ 115.08M$ 103.50M$ 94.50M
Gross Profit$ 115.41M$ 96.84M$ 103.76M$ 93.56M$ 85.39M
EBIT$ 12.05M$ -31.15M$ -6.50M$ 551.00K$ -16.24M
EBITDA$ 14.79M$ -28.46M$ -3.78M$ 3.50M$ -13.34M
Net Income Common Stockholders$ -15.70M$ -48.42M$ -33.84M$ -21.58M$ -43.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 260.06M$ 239.60M$ 286.20M$ 280.30M$ 265.63M
Total Assets$ 749.48M$ 721.79M$ 777.88M$ 764.08M$ 730.09M
Total Debt$ 444.06M$ 444.49M$ 445.06M$ 454.29M$ 452.17M
Net Debt$ 184.00M$ 204.89M$ 158.86M$ 173.99M$ 186.54M
Total Liabilities$ 616.96M$ 591.10M$ 617.71M$ 630.85M$ 618.51M
Stockholders Equity$ 180.71M$ 130.69M$ 160.17M$ 133.24M$ 111.58M
Cash Flow-
Free Cash Flow$ 21.59M$ -31.51M$ 1.73M$ -39.32M$ -18.67M
Operating Cash Flow$ 22.69M$ -29.70M$ 3.46M$ -37.76M$ -16.47M
Investing Cash Flow$ -21.98M$ 7.54M$ -23.96M$ 35.18M$ 50.34M
Financing Cash Flow$ -857.00K$ -13.31M$ 8.21M$ 37.62M$ 23.67M
Currency in USD

Amicus Earnings and Revenue History

Amicus Debt to Assets

Amicus Cash Flow

Amicus Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis